You just read:

4D pharma plc Enters Into Clinical Collaboration Agreement With MSD Investigating the Combination of KEYTRUDA® (pembrolizumab) and MRx0518 in Patients With Solid Tumours

News provided by

4D Pharma PLC

Jun 07, 2018, 02:00 ET